Pulmonary Vein Isolation Outcomes With Fish Oils (PUFA)

St. Luke's-Roosevelt Hospital Center

Status

Conditions: Atrial Fibrillation

Treatments: Drug: Lovaza (Fish Oils)

Study type: Expanded Access

Funder types: Other; Industry

Identifiers

NCT00841451

06-123

Details and patient eligibility

About

Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Paroxysmal Atrial fibrillation (PAF).
• Persistent atrial fibrillation. Persistent AF is not self-limited.

Exclusion criteria

• Previous pulmonary vein isolation ablation procedure
• Contraindication for anticoagulation
• Permanent AF
• Severe valvular pathology
• Concurrent use of antiarrhythmic medications
• Inability to give consent
• Pregnancy